Your browser doesn't support javascript.
loading
CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease.
Perugino, Cory A; Kaneko, Naoki; Maehara, Takashi; Mattoo, Hamid; Kers, Jesper; Allard-Chamard, Hugues; Mahajan, Vinay S; Liu, Hang; Della-Torre, Emanuel; Murphy, Samuel J H; Ghebremichael, Musie; Wallace, Zachary S; Bolster, Marcy B; Harvey, Liam M; Mylvaganam, Geetha; Tuncay, Yesim; Liang, Lloyd; Montesi, Sydney B; Zhang, Xiuwei; Tinju, Akira; Mochizuki, Keita; Munemura, Ryusuke; Sakamoto, Mizuki; Moriyama, Masafumi; Nakamura, Seiji; Yosef, Nir; Stone, John H; Pillai, Shiv.
Afiliación
  • Perugino CA; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
  • Kaneko N; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Maehara T; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Mattoo H; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Immunology and Inflammation Therapeutic Area, Sanofi, Cambridge, Mass.
  • Kers J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands; Van't Hoff Institute for Molecular Sciences (HIMS), University of Amsterda
  • Allard-Chamard H; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Division of Rheumatology, Faculté de médecine et des sciences de la santé de l' Université de Sherbrooke et Centre de Recherche Clinique Étienne-Le Bel, Sherbrooke Québec, Canada.
  • Mahajan VS; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Department of Pathology, Brigham and Women's Hospital, Boston, Mass.
  • Liu H; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Department of Rheumatology and Immunology, First Hospital of China Medical University, Shenyang, China.
  • Della-Torre E; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Murphy SJH; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass.
  • Ghebremichael M; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass.
  • Wallace ZS; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
  • Bolster MB; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
  • Harvey LM; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
  • Mylvaganam G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass.
  • Tuncay Y; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass.
  • Liang L; Division of Pulmonary & Critical Care Medicine, Massachusetts General Hospital, Boston, Mass.
  • Montesi SB; Division of Pulmonary & Critical Care Medicine, Massachusetts General Hospital, Boston, Mass.
  • Zhang X; University of California, Berkeley, Calif.
  • Tinju A; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Mochizuki K; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Munemura R; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Sakamoto M; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Moriyama M; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Nakamura S; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Yosef N; University of California, Berkeley, Calif.
  • Stone JH; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
  • Pillai S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass. Electronic address: pillai@helix.mgh.harvard.edu.
J Allergy Clin Immunol ; 147(1): 368-382, 2021 01.
Article en En | MEDLINE | ID: mdl-32485263
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Linfocitos T CD4-Positivos / Antígenos CD / Apoptosis / Células Madre Mesenquimatosas / Enfermedad Relacionada con Inmunoglobulina G4 Límite: Adult / Female / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Linfocitos T CD4-Positivos / Antígenos CD / Apoptosis / Células Madre Mesenquimatosas / Enfermedad Relacionada con Inmunoglobulina G4 Límite: Adult / Female / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos